CIK 1595725
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 75.34% | 65 |
| Health Care Equipment & Supplies | 12.40% | 11 |
| Unclassified | 5.95% | 10 |
| Health Care Providers & Services | 2.76% | 6 |
| Technology Hardware & Equipment | 0.98% | 2 |
| Insurance | 0.85% | 1 |
| Machinery | 0.71% | 1 |
| Professional Services | 0.36% | 1 |
| Commercial Services & Supplies | 0.30% | 1 |
| Life Sciences Tools & Services | 0.20% | 1 |
| Food & Staples Retailing | 0.17% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | Health Care | 6.93% |
| 2 | LLY | ELI LILLY & Co | Health Care | 5.35% |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Health Care | 5.28% |
| 4 | MIRM | Mirum Pharmaceuticals, Inc. | Health Care | 4.42% |
| 5 | ARGX | Argenx SE | Health Care | 4.24% |
| 6 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Health Care | 3.54% |
| 7 | INSM | INSMED Inc | Health Care | 3.03% |
| 8 | ASND | Ascendis Pharma A/S | Health Care | 2.62% |
| 9 | XENE | Xenon Pharmaceuticals Inc. | Health Care | 2.62% |
| 10 | TVTX | Travere Therapeutics, Inc. | Health Care | 2.59% |
90/100 names classified · sector 94.0% of weight · industry 94.0% · mkt cap 87.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 94.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 23% of book weight classified — the grid is NOT representative of the whole book.
Classified: 23.0% of book weight (24/95 names) · unclassified 77.0%: RVMD, MDGL, MIRM, ARGX, RYTM, , INSM, ASND, XENE, TVTX +61 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 1,209,465 | $118M | 6.9% | TRIM −9% |
| 2 | LLYELI LILLY & CO | 98,700 | $91M | 5.4% | TRIM −6% |
| 3 | MDGLMADRIGAL PHARMACEUTICALS INC | 170,999 | $90M | 5.3% | ADD 22% |
| 4 | MIRMMIRUM PHARMACEUTICALS INC | 811,294 | $75M | 4.4% | ADD 6% |
| 5 | ARGXARGENX SE | 98,500 | $72M | 4.2% | TRIM −5% |
| 6 | RYTMRHYTHM PHARMACEUTICALS INC | 689,748 | $60M | 3.5% | HOLD |
| 7 | INSMINSMED INC | 314,300 | $51M | 3.0% | HOLD |
| 8 | ASNDASCENDIS PHARMA A/S | 194,000 | $44M | 2.6% | TRIM −5% |
| 9 | XENEXENON PHARMACEUTICALS INC | 763,020 | $44M | 2.6% | TRIM −3% |
| 10 | TVTXTRAVERE THERAPEUTICS INC | 1,477,954 | $44M | 2.6% | TRIM −33% |
| 11 | KYMRKYMERA THERAPEUTICS INC | 496,871 | $41M | 2.4% | HOLD |
| 12 | PENPENUMBRA INC | 120,500 | $40M | 2.3% | HOLD |
| 13 | ISRGINTUITIVE SURGICAL INC | 82,000 | $38M | 2.2% | HOLD |
| 14 | SRRKSCHOLAR ROCK HLDG CORP | 739,816 | $36M | 2.1% | HOLD |
| 15 | ELVNENLIVEN THERAPEUTICS INC | 826,500 | $32M | 1.9% | ADD 4% |
| 16 | BSXBOSTON SCIENTIFIC CORP | 515,300 | $32M | 1.9% | ADD 29% |
| 17 | IRTCIRHYTHM HOLDINGS INC | 261,750 | $31M | 1.8% | ADD 11% |
| 18 | GPCRSTRUCTURE THERAPEUTICS INC | 640,217 | $31M | 1.8% | TRIM −14% |
| 19 | AGIOAGIOS PHARMACEUTICALS INC | 799,163 | $27M | 1.6% | HOLD |
| 20 | RAREULTRAGENYX PHARMACEUTICAL IN | 1,218,773 | $26M | 1.5% | TRIM −4% |
| 21 | ALNYALNYLAM PHARMACEUTICALS INC | 74,000 | $24M | 1.4% | ADD 4% |
| 22 | COGTCOGENT BIOSCIENCES INC | 624,155 | $24M | 1.4% | TRIM −26% |
| 23 | THCTenet Healthcare Corp. | 125,000 | $24M | 1.4% | HOLD |
| 24 | DXCMDEXCOM | 355,600 | $22M | 1.3% | ADD 2% |
| 25 | CLDXCELLDEX THERAPEUTICS INC NEW | 650,270 | $21M | 1.2% | TRIM −6% |
| 26 | VERAVERA THERAPEUTICS INC | 503,585 | $20M | 1.2% | TRIM −11% |
| 27 | NBIXNEUROCRINE BIOSCIENCES INC | 150,450 | $20M | 1.2% | ADD 20% |
| 28 | ARCELLX INC | 169,859 | $20M | 1.1% | HOLD |
| 29 | NAMSNEWAMSTERDAM PHARMA COMPANY | 588,794 | $19M | 1.1% | ADD 6% |
| 30 | PHVSPHARVARIS N V | 645,533 | $18M | 1.1% | ADD 4% |
| 31 | ERASERASCA INC | 1,103,469 | $18M | 1.1% | ADD 16% |
| 32 | DYNDYNE THERAPEUTICS INC | 972,198 | $18M | 1.0% | ADD 6% |
| 33 | CMPXCOMPASS THERAPEUTICS INC | 3,305,308 | $17M | 1.0% | TRIM −16% |
| 34 | ACRSACLARIS THERAPEUTICS INC | 4,472,650 | $17M | 1.0% | HOLD |
| 35 | TARSTARSUS PHARMACEUTICALS INC | 225,179 | $16M | 0.9% | TRIM −14% |
| 36 | MMEDMINIMED GROUP INC | 1,055,000 | $16M | 0.9% | NEW |
| 37 | ZLABZAI LAB LTD | 814,707 | $15M | 0.9% | HOLD |
| 38 | UNHUNITEDHEALTH GROUP INC | 53,000 | $14M | 0.8% | ADD 30% |
| 39 | CENTESSA PHARMACEUTICALS PLC | 351,828 | $14M | 0.8% | ADD 9% |
| 40 | HTFLHEARTFLOW INC | 572,500 | $14M | 0.8% | ADD 106% |
| 41 | ARDXARDELYX INC | 2,299,473 | $14M | 0.8% | HOLD |
| 42 | SMMTSUMMIT THERAPEUTICS INC | 710,000 | $13M | 0.8% | HOLD |
| 43 | AZTAAZENTA INC | 569,100 | $12M | 0.7% | HOLD |
| 44 | MLYSMINERALYS THERAPEUTICS INC | 439,751 | $12M | 0.7% | ADD 3% |
| 45 | DHRDANAHER CORP DEL | 61,500 | $12M | 0.7% | HOLD |
| 46 | PTCTPTC THERAPEUTICS INC | 161,798 | $11M | 0.6% | ADD 161% |
| 47 | CAICARIS LIFE SCIENCES INC | 563,000 | $10M | 0.6% | TRIM −18% |
| 48 | ZBIOZENAS BIOPHARMA INC | 502,077 | $10M | 0.6% | HOLD |
| 49 | BCAXBICARA THERAPEUTICS INC | 489,095 | $10M | 0.6% | ADD 14% |
| 50 | BBIOBRIDGEBIO PHARMA INC | 128,250 | $10M | 0.6% | ADD 24% |
| 51 | SOLENO THERAPEUTICS INC | 257,253 | $9M | 0.5% | ADD 4% |
| 52 | MBXMBX BIOSCIENCES INC | 287,967 | $9M | 0.5% | HOLD |
| 53 | TNGXTANGO THERAPEUTICS INC | 386,915 | $8M | 0.5% | HOLD |
| 54 | REGNREGENERON PHARMACEUTICALS | 10,100 | $8M | 0.5% | HOLD |
| 55 | IMNMIMMUNOME INC | 347,666 | $8M | 0.4% | HOLD |
| 56 | AMLXAMYLYX PHARMACEUTICALS INC | 499,764 | $7M | 0.4% | HOLD |
| 57 | OMDAOMADA HEALTH INC | 541,000 | $7M | 0.4% | TRIM −27% |
| 58 | INSPINSPIRE MED SYS INC | 131,800 | $7M | 0.4% | HOLD |
| 59 | APELLIS PHARMACEUTICALS INC | 162,750 | $7M | 0.4% | ADD 8% |
| 60 | ALKSALKERMES PLC | 183,986 | $7M | 0.4% | ADD 32% |
| 61 | EVHEVOLENT HEALTH INC | 2,675,000 | $6M | 0.4% | HOLD |
| 62 | INDVINDIVIOR PHARMACEUTICALS INC COM | 200,000 | $6M | 0.4% | NEW |
| 63 | TERNS PHARMACEUTICALS INC | 113,748 | $6M | 0.4% | ADD 5% |
| 64 | FOCLEDAP TMS S A | 1,378,000 | $5M | 0.3% | ADD 7% |
| 65 | JANXJANUX THERAPEUTICS INC | 367,009 | $5M | 0.3% | ADD 2% |
| 66 | PHRPHREESIA INC | 600,400 | $5M | 0.3% | TRIM −32% |
| 67 | TMOTHERMO FISHER SCIENTIFIC INC | 10,000 | $5M | 0.3% | HOLD |
| 68 | SYKSTRYKER CORPORATION | 14,800 | $5M | 0.3% | NEW |
| 69 | SIONSIONNA THERAPEUTICS INC | 99,429 | $4M | 0.2% | HOLD |
| 70 | RCUSARCUS BIOSCIENCES INC | 180,000 | $4M | 0.2% | HOLD |
| 71 | XBISPDR SERIES TRUST | 30,000 | $4M | 0.2% | TRIM −86% |
| 72 | ATECALPHATEC HLDGS INC | 350,000 | $4M | 0.2% | ADD 16% |
| 73 | PCVXVAXCYTE INC | 60,250 | $4M | 0.2% | ADD 28% |
| 74 | EYPTEYEPOINT INC | 258,739 | $3M | 0.2% | HOLD |
| 75 | NVONOVO-NORDISK A S | 90,000 | $3M | 0.2% | NEW |
| 76 | OCULOCULAR THERAPEUTIX INC | 383,716 | $3M | 0.2% | ADD 11% |
| 77 | VKTXVIKING THERAPEUTICS INC | 96,000 | $3M | 0.2% | NEW |
| 78 | CYTKCYTOKINETICS INC | 45,364 | $3M | 0.2% | ADD 27% |
| 79 | IPSCCENTURY THERAPEUTICS INC | 1,304,347 | $3M | 0.2% | NEW |
| 80 | CVSCVS HEALTH CORP | 40,000 | $3M | 0.2% | NEW |
| 81 | ROIVROIVANT SCIENCES LTD | 97,000 | $3M | 0.2% | ADD 9% |
| 82 | TLPHTALPHERA INC | 3,589,186 | $3M | 0.2% | HOLD |
| 83 | OLMAOLEMA PHARMACEUTICALS INC | 170,378 | $3M | 0.1% | ADD 73% |
| 84 | SGRYSURGERY PARTNERS INC | 208,000 | $2M | 0.1% | TRIM −33% |
| 85 | LENZLENZ THERAPEUTICS INC | 257,460 | $2M | 0.1% | HOLD |
| 86 | EWEDWARDS LIFESCIENCES CORP | 28,900 | $2M | 0.1% | TRIM −65% |
| 87 | DNTHDIANTHUS THERAPEUTICS INC | 26,757 | $2M | 0.1% | NEW |
| 88 | NGNENEUROGENE INC | 104,339 | $2M | 0.1% | HOLD |
| 89 | AGLAGILON HEALTH INC COM NEW | 260,000 | $2M | 0.1% | NEW |
| 90 | CORTCORCEPT THERAPEUTICS INC | 50,250 | $2M | 0.1% | HOLD |
| 91 | ACHCACADIA HEALTHCARE COMPANY IN | 75,500 | $2M | 0.1% | TRIM −37% |
| 92 | TEVATEVA PHARMACEUTICAL INDS LTD | 45,500 | $1M | 0.1% | HOLD |
| 93 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 61,700 | $1M | 0.1% | HOLD |
| 94 | JAZZJAZZ PHARMACEUTICALS PLC | 5,750 | $1M | 0.1% | ADD 229% |
| 95 | JSPRJASPER THERAPEUTICS INC | 1,100,726 | $964,456 | 0.1% | HOLD |
| 96 | LEGNLEGEND BIOTECH CORP | 40,500 | $732,645 | 0.0% | ADD 20% |
| 97 | GOSSGOSSAMER BIO INC | 1,609,492 | $528,718 | 0.0% | TRIM −51% |
| 98 | AMICUS THERAPEUTICS INC | 21,062 | $304,557 | 0.0% | TRIM −99% |
| 99 | ORKAORUKA THERAPEUTICS INC | 4,123 | $202,233 | 0.0% | NEW |
| 100 | BCRXBIOCRYST PHARMACEUTICALS INC | 12,600 | $119,952 | 0.0% | NEW |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 1.2M | 1.3M | 1.3M | 1.3M | 1.3M | 1.2M | $118M |
| LLYELI LILLY & CO | 145K | 114K | 117K | 105K | 105K | 99K | $91M |
| MDGLMADRIGAL PHARMACEUTICALS INC | 265K | 167K | 140K | 138K | 140K | 171K | $90M |
| MIRMMIRUM PHARMACEUTICALS INC | 1.5M | 952K | 818K | 761K | 762K | 811K | $75M |
| ARGXARGENX SE | 230K | 176K | 176K | 143K | 103K | 99K | $72M |
| RYTMRHYTHM PHARMACEUTICALS INC | 1.2M | 834K | 861K | 717K | 695K | 690K | $60M |
| INSMINSMED INC | 550K | 516K | 525K | 385K | 319K | 314K | $51M |
| ASNDASCENDIS PHARMA A/S | 305K | 216K | 217K | 215K | 204K | 194K | $44M |
| XENEXENON PHARMACEUTICALS INC | 1.3M | 932K | 932K | 852K | 788K | 763K | $44M |
| TVTXTRAVERE THERAPEUTICS INC | 5.0M | 2.9M | 1.9M | 2.2M | 2.2M | 1.5M | $44M |
| KYMRKYMERA THERAPEUTICS INC | 1.0M | 794K | 450K | 450K | 497K | 497K | $41M |
| PENPENUMBRA INC | 240K | 171K | 129K | 121K | 121K | 121K | $40M |
| ISRGINTUITIVE SURGICAL INC | 216K | 102K | 82K | 82K | 82K | 82K | $38M |
| SRRKSCHOLAR ROCK HLDG CORP | 717K | 762K | 794K | 794K | 733K | 740K | $36M |
| ELVNENLIVEN THERAPEUTICS INC | 429K | 466K | 701K | 686K | 798K | 827K | $32M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
